US5322851A
(en)
*
|
1990-07-02 |
1994-06-21 |
H. Lundbeck A/S |
Indole derivatives
|
EP0592669B1
(en)
*
|
1991-05-20 |
1998-01-28 |
Chisso Corporation |
Optically active trifluorolactic acid derivative and liquid crystal composition
|
DK78692D0
(da)
*
|
1992-06-12 |
1992-06-12 |
Lundbeck & Co As H |
Dimere piperidin- og piperazinderivater
|
DE4439836C1
(de)
*
|
1994-11-08 |
1996-06-05 |
Hoechst Ag |
cis-4-(2,2,3,3-Tetrafluorpropoxy)-zimtsäurenitril und trans-4-(2,2,3,3-Tetrafluorpropoxy)- zimtsäurenitril und ein Verfahren zu ihrer Herstellung
|
UA62985C2
(en)
*
|
1997-11-10 |
2004-01-15 |
Lunnbeck As H |
A method for the preparation of citalopram
|
DK1123284T3
(da)
*
|
1998-10-20 |
2003-04-28 |
Lundbeck & Co As H |
Fremgangsmåde til fremstilling af citalopram
|
CZ300408B6
(cs)
|
1998-12-23 |
2009-05-13 |
H. Lundbeck A/S |
Zpusob výroby 5-kyanoftalidu
|
AR022329A1
(es)
|
1999-01-29 |
2002-09-04 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-cianoftalida
|
NZ514671A
(en)
*
|
1999-04-14 |
2003-10-31 |
H |
Method for the preparation of citalopram
|
US6245782B1
(en)
|
1999-05-17 |
2001-06-12 |
Heartdrug Research L.L.C. |
Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
|
ITMI991579A1
(it)
|
1999-06-25 |
2001-01-15 |
Lundbeck & Co As H |
Metodo per la preparazione di citalopram
|
ITMI991581A1
(it)
*
|
1999-06-25 |
2001-01-15 |
Lundbeck & Co As H |
Metodo per la preparazione di citalopram
|
AR021155A1
(es)
*
|
1999-07-08 |
2002-06-12 |
Lundbeck & Co As H |
Tratamiento de desordenes neuroticos
|
US6403657B1
(en)
|
1999-10-04 |
2002-06-11 |
Martin C. Hinz |
Comprehensive pharmacologic therapy for treatment of obesity
|
US6759437B2
(en)
|
1999-10-04 |
2004-07-06 |
Martin C. Hinz |
Comprehensive pharmacologic therapy for treatment of obesity including cysteine
|
ES2282365T3
(es)
|
1999-10-25 |
2007-10-16 |
H. Lundbeck A/S |
Metodo para la preparacion de citalopram.
|
SK287139B6
(sk)
*
|
1999-10-25 |
2010-01-07 |
H. Lundbeck A/S |
Spôsob prípravy citalopramu
|
AR026063A1
(es)
|
1999-11-01 |
2002-12-26 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-carboxiftalida.
|
UA77650C2
(en)
*
|
1999-12-06 |
2007-01-15 |
Lundbeck & Co As H |
Use of serotonin reuptake inhibitor in combination with deramcyclane
|
ATE261953T1
(de)
*
|
1999-12-28 |
2004-04-15 |
Lundbeck & Co As H |
Verfahren zur herstellung von citalopram
|
HUP0300343A2
(hu)
*
|
2000-01-14 |
2003-06-28 |
H. Lundbeck A/S |
Eljárás 5-cianoftalid előállítására
|
FR2805812A1
(fr)
|
2000-02-24 |
2001-09-07 |
Lundbeck & Co As H |
Procede de preparation du citalopram
|
IES20010157A2
(en)
|
2000-03-03 |
2002-03-06 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
GB0005477D0
(en)
|
2000-03-07 |
2000-04-26 |
Resolution Chemicals Limited |
Process for the preparation of citalopram
|
EA200200968A1
(ru)
*
|
2000-03-13 |
2003-02-27 |
Х.Лундбекк А/С |
Поэтапное алкилирование 5-замещенных 1-(4-фторфенил)-1,3-дигидроизобензофуранов
|
IES20010206A2
(en)
|
2000-03-13 |
2002-03-06 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
GB2357762B
(en)
*
|
2000-03-13 |
2002-01-30 |
Lundbeck & Co As H |
Crystalline base of citalopram
|
EP1265883A1
(en)
*
|
2000-03-13 |
2002-12-18 |
H. Lundbeck A/S |
Method for the preparation of citalopram
|
KR20020080476A
(ko)
|
2000-03-14 |
2002-10-23 |
하. 룬트벡 아크티에 셀스카브 |
시탈로프람의 제조 방법
|
WO2001068632A1
(en)
*
|
2000-03-16 |
2001-09-20 |
H. Lundbeck A/S |
Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
|
AR032455A1
(es)
|
2000-05-12 |
2003-11-12 |
Lundbeck & Co As H |
Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
|
EA008372B1
(ru)
*
|
2000-07-07 |
2007-04-27 |
Х.Лундбекк А/С |
Применение эсциталопрама для лечения расстройства, связанного с социальной тревогой
|
EA008373B1
(ru)
*
|
2000-07-07 |
2007-04-27 |
Х. Лундбекк А/С |
Применение эсциталопрама для лечения расстройства, связанного с посттравматическим стрессом
|
JP2004510705A
(ja)
*
|
2000-07-20 |
2004-04-08 |
ラウラス エイエス |
方法
|
CA2353693C
(en)
*
|
2000-08-10 |
2003-07-22 |
H. Lundbeck A/S |
Pharmaceutical composition containing citalopram
|
FI20011622A
(fi)
|
2000-08-18 |
2002-02-19 |
Lundbeck & Co As H |
Menetelmä sitalopraamin valmistamiseksi
|
US20030109577A1
(en)
*
|
2000-10-27 |
2003-06-12 |
Ken Liljegren |
Pharmaceutical composition containing citalopram
|
US20030232881A1
(en)
*
|
2000-10-27 |
2003-12-18 |
H. Lundbeck A/S |
Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
|
ATE222899T1
(de)
*
|
2000-12-28 |
2002-09-15 |
Lundbeck & Co As H |
Verfahren zur herstellung von reinem citalopram
|
CA2435925A1
(en)
*
|
2001-01-30 |
2002-08-08 |
Orion Corporation Fermion |
Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
|
WO2002087566A1
(en)
*
|
2001-05-01 |
2002-11-07 |
H. Lundbeck A/S |
The use of enantiomeric pure escitalopram
|
BG65271B1
(bg)
*
|
2001-06-18 |
2007-11-30 |
H. Lundbeck A/S |
Метод за получаване на циталопрам
|
AR034612A1
(es)
*
|
2001-06-25 |
2004-03-03 |
Lundbeck & Co As H |
Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
|
AR034759A1
(es)
*
|
2001-07-13 |
2004-03-17 |
Lundbeck & Co As H |
Metodo para la preparacion de escitalopram
|
DK1414435T3
(da)
*
|
2001-07-31 |
2005-05-09 |
Lundbeck & Co As H |
Krystallinsk komposition indeholdende escitalopram
|
DK1281707T3
(da)
*
|
2001-08-02 |
2005-05-02 |
Infosint Sa |
Fremgangsmåde til fremstilling af 5-substituerede isobenzenfuraner
|
IS7239A
(is)
*
|
2001-12-14 |
2004-04-29 |
H. Lundbeck A/S |
Aðferð til framleiðslu á essítalóprami
|
AU2003222435A1
(en)
*
|
2002-01-07 |
2003-07-24 |
Sun Pharmaceutical Industries Limited |
Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
|
WO2003064617A2
(en)
*
|
2002-01-30 |
2003-08-07 |
Montana State University |
Pestalotiopsis microsporia isolates and compounds derived therefrom
|
EP1346989A1
(en)
*
|
2002-03-21 |
2003-09-24 |
Jubilant Organosys Limited |
Improved process for the preparation of citalopram and its hydrobromide
|
CA2381341A1
(en)
*
|
2002-04-09 |
2003-10-09 |
Torcan Chemical Ltd. |
Process and intermediates for preparing escitalopram
|
FI20021421A0
(fi)
*
|
2002-07-30 |
2002-07-30 |
Orion Corp Fermion |
Valmistusmenetelmä
|
TWI306846B
(en)
*
|
2002-08-12 |
2009-03-01 |
Lundbeck & Co As H |
Method for the separation of intermediates which may be used for the preparation of escitalopram
|
US6812355B2
(en)
|
2002-10-22 |
2004-11-02 |
Sekhsaria Chemicals Limited |
Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
|
EP1581483B1
(en)
*
|
2002-12-23 |
2012-06-06 |
H. Lundbeck A/S |
A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR i S- /i OR i R- /i CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, i R- /i CITALOPRAM AND/OR i S- /i CITALOPRAM
|
US20050137255A1
(en)
*
|
2002-12-23 |
2005-06-23 |
H. Lundbeck A/S |
Crystalline escitalopram hydrobromide and methods for preparing the same
|
ME00034B
(me)
*
|
2002-12-23 |
2010-02-10 |
H Lundbeck As |
Postupak pripremanja racemskog citalopram diola i/ili r-citalopram diola i upotreba takvih diola za pripremanje racemskog citaloprama, r-citaloprama i/ili s-citaloprama
|
ES2298595T3
(es)
*
|
2002-12-23 |
2008-05-16 |
H. Lundbeck A/S |
Hidrobromuro de escitalopram y un metodo para su preparacion.
|
EP1611118A2
(en)
*
|
2003-03-21 |
2006-01-04 |
H. Lundbeck A/S |
Intermediates for the preparation of citalopram and escitalopram
|
TR200504022T1
(tr)
*
|
2003-03-24 |
2006-08-21 |
Hetero Drugs Limited |
(S)-sitalopram oksalatın yeni sıvı kristal formları.
|
US7019153B2
(en)
|
2003-06-10 |
2006-03-28 |
Sun Pharmaceutical Industries Limited |
Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
|
ATE449633T1
(de)
|
2003-09-12 |
2009-12-15 |
Pfizer |
Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
|
ES2228274B1
(es)
*
|
2003-09-24 |
2006-06-01 |
Astur Pharma, S.A. |
Sintesis quimioenzimatica de (+)-citalopram y (-)-citalopram.
|
ATE293106T1
(de)
*
|
2003-10-28 |
2005-04-15 |
Adorkem Technology Spa |
Verfahren zur herstellung von citalopram
|
US20050101666A1
(en)
*
|
2003-11-07 |
2005-05-12 |
H. Lundbeck A/S |
Method of treating premenstrual dysphoric disorder with escitalopram
|
CA2575975A1
(en)
*
|
2003-11-12 |
2005-05-26 |
Dr. Reddy's Laboratories, Inc. |
Preparation of escitalopram
|
US20050107466A1
(en)
*
|
2003-11-17 |
2005-05-19 |
H. Lundbeck A/S |
Method of treating or reducing suicidal thoughts with escitalopram
|
US20050143350A1
(en)
*
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
AU2003282383A1
(en)
*
|
2003-11-20 |
2005-06-08 |
Natco Pharma Limited |
A process for the preparation of high purity escitalopram
|
CN100569765C
(zh)
*
|
2003-12-19 |
2009-12-16 |
杭州民生药业集团有限公司 |
西酞普兰中间体晶体碱
|
TWI339651B
(en)
*
|
2004-02-12 |
2011-04-01 |
Lundbeck & Co As H |
Method for the separation of intermediates which may be used for the preparation of escitalopram
|
US20050196453A1
(en)
*
|
2004-03-05 |
2005-09-08 |
H. Lundbeck A/S |
Crystalline composition containing escitalopram
|
EA200601641A1
(ru)
*
|
2004-03-05 |
2006-12-29 |
Х. Лундбекк А/С |
Кристаллическая композиция, содержащая оксалат эсциталопрама
|
ITMI20040717A1
(it)
|
2004-04-09 |
2004-07-09 |
Adorkem Technology Spa |
Procedimento chemo-enzimatico per la preparazione dell'escitalopram
|
US20050233010A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Satow Philip M |
Lithium combinations, and uses related thereto
|
PE20060437A1
(es)
|
2004-06-18 |
2006-06-08 |
Novartis Ag |
COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
|
WO2006006071A1
(en)
*
|
2004-07-07 |
2006-01-19 |
Pfizer Products Inc. |
Resolution of an aryl-fused azapolycyclic compound
|
KR101166280B1
(ko)
*
|
2004-08-23 |
2013-11-27 |
썬 파마 글로벌 에프제트이 |
시탈로프램 및 에난티오머의 제조 방법
|
US7989645B2
(en)
*
|
2004-08-23 |
2011-08-02 |
Sun Pharma Global Fze |
Process for preparation of citalopram and enantiomers
|
WO2006025071A1
(en)
*
|
2004-09-02 |
2006-03-09 |
Natco Pharma Limited |
A process for the preparation of escitalopram
|
ITMI20041872A1
(it)
|
2004-10-01 |
2005-01-01 |
Adorkem Technology Spa |
Processo per la preparazione di citalopram e di scitalopram
|
EP1877394A1
(en)
*
|
2005-04-04 |
2008-01-16 |
Jubilant Organosys Limited |
Process for the preparation of escitalopram or its acid addition salts
|
GB0507298D0
(en)
|
2005-04-11 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
JP2008538572A
(ja)
|
2005-04-22 |
2008-10-30 |
ワイス |
ジヒドロベンゾフラン誘導体およびその使用
|
CN101203218A
(zh)
*
|
2005-04-22 |
2008-06-18 |
惠氏公司 |
苯并呋喃基链烷胺衍生物和其作为5-ht2c激动剂的用途
|
TW200719886A
(en)
*
|
2005-04-22 |
2007-06-01 |
Wyeth Corp |
Dihydrobenzofuran derivatives and uses thereof
|
WO2006116165A1
(en)
*
|
2005-04-22 |
2006-11-02 |
Wyeth |
Chromane and chromene derivatives and uses thereof
|
ITTO20050301A1
(it)
*
|
2005-05-05 |
2006-11-06 |
Errekappa Euroterapici Spa |
Formulazioni liquide orali contenenti citalopram
|
EP1901714A2
(en)
*
|
2005-05-20 |
2008-03-26 |
Aurobindo Pharma Limited |
Pharmaceutical dosage forms comprising escitalopram in form of granules
|
US7834201B2
(en)
|
2005-06-22 |
2010-11-16 |
H. Lundbeck A/S |
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
|
TWI347942B
(en)
|
2005-06-22 |
2011-09-01 |
Lundbeck & Co As H |
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
|
WO2007012954A1
(en)
*
|
2005-07-27 |
2007-02-01 |
Aurobindo Pharma Limited |
An improved process for the preparation of escitalopram
|
WO2007048080A2
(en)
*
|
2005-10-14 |
2007-04-26 |
Forest Laboratories, Inc. |
Stable pharmaceutical formulations containing escitalopram and bupropion
|
EP1954257A4
(en)
*
|
2005-10-14 |
2009-05-20 |
Lundbeck & Co As H |
METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION
|
US20090247772A1
(en)
*
|
2005-11-14 |
2009-10-01 |
H. Lundbeck A/S |
Method for the Preparation of Escitalopram
|
GB0525672D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
GB0525673D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
GB0601286D0
(en)
|
2006-01-23 |
2006-03-01 |
Sandoz Ag |
Asymmetric synthesis
|
FR2912057B1
(fr)
*
|
2007-02-07 |
2009-04-17 |
Sanofi Aventis Sa |
Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
|
PA8720801A1
(es)
*
|
2006-03-24 |
2008-11-19 |
Wyeth Corp |
Nuevas combinaciones terapeuticas para el tratamiento de la depresion
|
US20070259952A1
(en)
*
|
2006-05-02 |
2007-11-08 |
H. Lundbeck A/S |
Uses of escitalopram
|
TW200817003A
(en)
*
|
2006-07-31 |
2008-04-16 |
Sanofi Aventis |
Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
|
RU2463039C2
(ru)
*
|
2006-10-20 |
2012-10-10 |
Рациофарм Гмбх |
Эсциталопрам и твердая фармацевтическая композиция, его содержащая
|
JP5404048B2
(ja)
|
2006-10-27 |
2014-01-29 |
久光製薬株式会社 |
貼付剤
|
US20080153880A1
(en)
*
|
2006-12-22 |
2008-06-26 |
Allergan, Inc. |
Pan-alpha-2 receptor agonist and acid reducer compositions for treating gastrointestinal motility disorders
|
US20080153825A1
(en)
*
|
2006-12-22 |
2008-06-26 |
Allergan Inc. |
Alpha-2b receptor agonist and 5ht4 serotonin receptor compositions for treating gastrointestinal motility disorders
|
US20080153881A1
(en)
*
|
2006-12-22 |
2008-06-26 |
Allergan, Inc. |
Alpha-2b receptor agonist and acid reducer compositions for treating gastrointestinal motility disorders
|
US20080153808A1
(en)
*
|
2006-12-22 |
2008-06-26 |
Allergan, Inc. |
Alpha-2 receptor pan agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain
|
US20080153874A1
(en)
*
|
2006-12-22 |
2008-06-26 |
Allergan Inc. |
Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain
|
US20080153927A1
(en)
*
|
2006-12-22 |
2008-06-26 |
Allergan, Inc. |
Alpha-2b receptor agonist and relaxant compositions for treating gastrointestinal motility disorders
|
US20080153832A1
(en)
*
|
2006-12-22 |
2008-06-26 |
Allergan, Inc. |
Pan-alpha-2 receptor agonist and relaxant compositions for treating gastrointestinal motility disorders
|
EP2134325A2
(en)
*
|
2007-03-01 |
2009-12-23 |
Aurobindo Pharma Limited |
Stable solid dosage forms of an antidepressant
|
PT1988086E
(pt)
*
|
2007-04-23 |
2012-02-28 |
Synthon Bv |
Processo para a resolução de citalopram via o seu composto tartarato de citalopram enriquecido em (s)
|
NZ580738A
(en)
|
2007-05-18 |
2012-02-24 |
Cipla Ltd |
Process for the preparation of escitalopram
|
US20080312318A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Protia, Llc |
Deuterium-enriched escitalopram
|
EP2017271A1
(en)
|
2007-07-06 |
2009-01-21 |
Aurobindo Pharma Limited |
Process for the preparation of escitalopram
|
HUE036004T2
(hu)
*
|
2007-08-03 |
2018-06-28 |
Richter Gedeon Nyrt |
Dopamin receptor ligandumokat tartalmazó gyógyszerkészítmények és kezelési eljárások dopamin receptor ligandumok alkalmazásával
|
US20090048336A1
(en)
*
|
2007-08-17 |
2009-02-19 |
Naveen Kumar Kolla |
Escitalopram oxalate powders
|
US8022232B2
(en)
|
2007-09-11 |
2011-09-20 |
H. Lundbeck A/S |
Method for manufacture of escitalopram
|
FI121570B
(fi)
*
|
2007-09-11 |
2011-01-14 |
Lundbeck & Co As H |
Menetelmä essitalopraamin valmistamiseksi
|
US9339500B2
(en)
*
|
2008-03-04 |
2016-05-17 |
Intra-Cellular Therapies, Inc. |
Methods of treating vasomotor symptoms
|
CN101538257B
(zh)
*
|
2008-03-21 |
2012-10-17 |
浙江华海药业股份有限公司 |
一种制备西酞普兰和s-西酞普兰的方法
|
CN101265215B
(zh)
*
|
2008-04-18 |
2011-03-16 |
浙江奥托康制药集团股份有限公司 |
一种右旋西酞普兰中间体s-型二醇的制备方法
|
WO2009128057A2
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
EP2116231A1
(en)
|
2008-05-07 |
2009-11-11 |
Hexal Ag |
Granulate comprising escitalopram oxalate
|
WO2009147687A2
(en)
*
|
2008-06-03 |
2009-12-10 |
Shodhana Laboratories Limited |
An improved process for the separation of enantiomerically pure compounds
|
WO2010004575A2
(en)
*
|
2008-06-16 |
2010-01-14 |
Shodhana Laboratories Limited |
Preparation of escitalopram, its salts and intermediates
|
GR20080100696A
(el)
|
2008-10-23 |
2010-05-13 |
Genepharm �.�. |
Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
|
WO2010098230A1
(ja)
*
|
2009-02-27 |
2010-09-02 |
久光製薬株式会社 |
経皮投与製剤
|
US20100249438A1
(en)
*
|
2009-03-30 |
2010-09-30 |
Vijaya Bhaskar Bolugoddu |
Preparation of escitalopram
|
US8829020B2
(en)
|
2009-07-16 |
2014-09-09 |
Mallinckrodt Llc |
Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
|
CN102190600B
(zh)
*
|
2010-03-13 |
2015-04-15 |
浙江华海药业股份有限公司 |
一种右旋西酞普兰中间体s-型二醇的制备方法
|
CN102757414B
(zh)
*
|
2011-04-25 |
2014-02-19 |
齐鲁制药有限公司 |
艾司西酞普兰草酸盐的制备方法
|
WO2013081567A1
(en)
|
2011-12-02 |
2013-06-06 |
Mahmut Bilgic |
Effervescent antipsychotic formulations
|
WO2013100870A1
(en)
|
2011-12-02 |
2013-07-04 |
Mahmut Bilgic |
New antipsychotic compositions
|
ITMI20120105A1
(it)
*
|
2012-01-30 |
2013-07-31 |
Carthesia S A S |
Soluzione acquosa di escitalopram ossalato e relativo utilizzo
|
ITMI20120448A1
(it)
|
2012-01-30 |
2013-07-31 |
Carthesia Sas |
Composizione liofilizzata di escitalopram ossalato per somministrazione sublinguale
|
CN104119248A
(zh)
*
|
2014-08-08 |
2014-10-29 |
广东东阳光药业有限公司 |
S-西酞普兰的制备方法
|
US10287240B2
(en)
*
|
2014-11-14 |
2019-05-14 |
Zhejiang Hushai Pharmaceuticals Co., Ltd. |
Method for resolution of citalopram intermediate 5-cyano diol
|
WO2016197320A1
(zh)
|
2015-06-09 |
2016-12-15 |
浙江华海药业股份有限公司 |
一种西酞普兰二醇中间体的制备方法
|
CN107311968A
(zh)
*
|
2016-03-31 |
2017-11-03 |
广州市恒诺康医药科技有限公司 |
西酞普兰帕莫酸盐和其结晶形态及其制备方法和用途
|
CN108976188B
(zh)
*
|
2017-06-05 |
2022-12-06 |
上海奥博生物医药股份有限公司 |
一种艾司西酞普兰双羟萘酸盐新的制备方法
|
AU2018349284B2
(en)
|
2017-10-09 |
2023-11-16 |
428 Pharma BV. |
New salt and solid state forms of escitalopram
|
CN111217777A
(zh)
|
2018-11-26 |
2020-06-02 |
上海奥博生物医药技术有限公司 |
一种高纯度艾司西酞普兰双羟萘酸盐新的制备工艺
|
US20240024288A1
(en)
|
2019-07-19 |
2024-01-25 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
KR102441089B1
(ko)
|
2020-06-15 |
2022-09-07 |
환인제약 주식회사 |
의약 조성물
|
US20240100012A1
(en)
|
2021-01-18 |
2024-03-28 |
Mark Hasleton |
Pharmaceutical dosage form
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|